86. Pulmonary arterial hypertension Clinical trials / Disease details
Clinical trials : 1,181 / Drugs : 701 - (DrugBank : 126) / Drug target genes : 105 - Drug target pathways : 192
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT03617458 (ClinicalTrials.gov) | August 23, 2018 | 2/5/2018 | Interventions Against Insulin Resistance in Pulmonary Arterial Hypertension | Interventions Against Insulin Resistance in Pulmonary Arterial Hypertension | Pulmonary Artery Hypertension | Drug: Metformin;Drug: Placebo;Device: mHealth Intervention;Device: Usual Care | Vanderbilt University Medical Center | Mayo Clinic;The Cleveland Clinic | Recruiting | 18 Years | N/A | All | 130 | Phase 2 | United States |